H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on ALX Oncology Holdings (ALXO - Research Report) today and set a price target of $65.00. The company's shares closed yesterday at $12.50.According to TipRanks, Ramakanth is an analyst with an average return of -14.7% and a 28.76% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as ImmunoGen, MiMedx Group, and Rewalk Robotics.The word on The Street in general, suggests a Moderate Buy analyst consensus rating for ALX Oncology Holdings with a $65.00 average price target.
https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-buy-rating-for-alx-oncology-holdings-alxo?utm_source=advfn.com&utm_medium=referral
ALX Oncology (NASDAQ:ALXO)
Historical Stock Chart
From Feb 2023 to Mar 2023 Click Here for more ALX Oncology Charts.
ALX Oncology (NASDAQ:ALXO)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more ALX Oncology Charts.